Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non‐small cell lung cancer patients-Reference-Cited by-同舟云学术

Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non‐small cell lung cancer patients

Published:2019-12-03 Issue:2 Volume:9 Page:605-614
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Grenda Anna¹,Błach Justyna¹²^ORCID,Szczyrek Michał¹,Krawczyk Paweł¹^ORCID,Nicoś Marcin¹³,Kuźnar Kamińska Barbara⁴,Jakimiec Monika¹,Balicka Grażyna⁵,Chmielewska Izabela¹,Batura‐Gabryel Halina⁴,Sawicki Marek⁵,Milanowski Janusz¹

Affiliation:

1. Department of Pneumonology, Oncology and Allergology Medical University of Lublin Lublin Poland

2. Department of Clinical Immunology Medical University of Lublin Lublin Poland

3. Science for Life Laboratory Department of Medical Biochemistry and BiophysicsKarolinska Institutet Stockholm Sweden

4. Department of Pulmonology, Allergology and Respiratory Oncology University of Medical Sciences in Poznań Poznań Poland

5. Department of Thoracic Surgery Medical University of Lublin Lublin Poland

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2743